“`html
The average one-year price target for Eli Lilly (NYSE: LLY) has been revised to $1,020.92 per share, marking a 10.15% increase from $926.82 on November 7, 2025. The new target ranges from a low of $713.10 to a high of $1,575.00, which represents a decrease of 0.43% from the latest closing price of $1,025.28 per share.
As of the last quarter, there are 5,592 funds reporting positions in Eli Lilly, an increase of 18 owners or 0.32%. Total shares owned by institutions decreased by 3.76% to 875,693K shares. The put/call ratio stands at 0.76, indicating a bullish market outlook.
Lilly Endowment holds 95,493K shares (10.67% ownership) but has decreased its holdings by 0.55%. PNC Financial Services Group holds 51,364K shares (5.74% ownership), increasing its shares by 0.14% despite reducing its portfolio allocation in LLY by 85.40% last quarter.
“`
